Blog

April 27, 2018

Götti Wins Frame of the Year at Optician Awards

The Optician Awards 2018 Frame of the Year prize went to the DC05 sunglasses of Götti’s Perspective Collection. The Optician Awards were held during Optrafair at the Birmingham Hilton Metropole on Saturday, April 14th.

“For me, rimless glasses are the most prestigious discipline in the design of glasses. Achieving the technical requirements with so few materials took over eight years of development. We are very pleased that the jury has honoured this innovation with this award,” says designer and owner, Sven Götti.

Click HERE for the full press release.

April 26, 2018April 28, 2018

NEI Study Finds Omega-3 No Better than Placebo for Dry Eye

A trial conducted by the Dry Eye Assessment and Management (DREAM) research group found that omega-3 supplements did not outperform the placebo over a period of 12 months.

The trial involved 535 participants who had at least a six-month history of moderate to severe dry eye. 349 participants received a daily dose of 3 grams of omega-3 fatty acids in capsule form, while the remaining 186 participants received an olive oil placebo.¹ The results of the study were published in the April 13 edition of the New England Journal of Medicine.

Participants were allowed to continue taking their previous dry eye medications, including artificial tears and anti-inflammatory eyedrops. “Omega-3s are generally used as an add-on therapy. The study results are in the context of this real-world experience of treating symptomatic dry eye patients who request additional treatment,” said study chair for the trial, Penny A. Asbell, M.D., of the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai in New York City. Fish oil omega-3 supplements are a $200-million a year market in Canada.²

Patient reported symptoms were recorded using the Ocular Surface Disease Index, a 100 point scale that measures dry eye severity. After the 12 month trial period both groups reported significant improvement (13.9 points on average for the omega-3 group and 12.5 points for the placebo group) but the difference between the groups was not considered statistically significant.

“The findings also emphasize the difficulty in judging whether a treatment really helps a particular dry eye patient,” said the leader of the coordinating center for the study, Maureen G. Maguire, Ph.D., of the Department of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia. “More than half the people taking placebo reported substantial symptom improvement during the year-long study.”

A majority of the study participants (61% in the omega-3 group and 54% in the placebo group) reported an improvement of ten points or more on the OSDI scale. Standardized tests measuring tear quality and amount and conjunctiva health also did not show significant differences.

“The trial provides the most reliable and generalizable evidence thus far on omega-3 supplementation for dry eye disease,” said Maryann Redford, D.D.S., M.P.H., program officer for clinical research at NEI. “This well-controlled investigation conducted by the independently-led Dry Eye Assessment and Management (DREAM) Research Group shows that omega-3 supplements are no better than placebo for typical patients who suffer from dry eye.”

https://www.nei.nih.gov/content/omega-3s-fish-oil-supplements-no-better-placebo-dry-eye
http://www.cbc.ca/news/health/marketplace-fish-oil-omega-3-benefits-safety-1.3326587

April 24, 2018April 24, 2018

UW Optometry Professor Kristine Dalton to Receive Teaching Award

The Faculty of Science have honoured Prof. Kristine Dalton and Dr. Rick Marta as this year’s Excellence in Science Teaching Award (ESTA) winners for their dedication to hands-on learning and mentorship. Teaching is a core mission at the University of Waterloo and this prestigious award acknowledges the special role Science faculty members play in inspiring the next generation of science and technology professionals.

Kristine Dalton is an assistant professor in the School of Optometry & Vision Science. She has been a pioneer in the field of sports vision, establishing and directing Canada’s first Sports Vision Clinic at the University of Waterloo, which has expanded to include the new Brain Injury Clinic.

“Modeling the change we seek to promote, Kristine is already creating a lasting impact and enhancing our School’s reputation for innovation and excellence in teaching,” says Prof. Stan Woo, Director of the School of Optometry & Vision Science.

Dalton’s students praise her dedication in-and-outside the classroom, whether she is teaching a large class, supervising a graduate student, or training students in a clinical setting. Her hard work and unique qualifications as an educator, professional optometrist and outstanding researcher have been inspiring to students, who consider her a role model and mentor.

April 20, 2018April 24, 2018

Novartis Delivers Strong First Quarter in 2018

Net sales for the first quarter of 2018 were CAD 16.1 billion, an increase of 4% at constant currencies. Core operating income also grew by 4%.

Alcon’s sales continued to grow (+7%) and core operating income increased by 29% “as a result of improved operations, customer relationships and product launches.” Alcon’s net sales were CAD 2.3 billion in the first quarter, with an 8% growth in Surgical and a 5% growth in Vision Care, driven by a double-digit growth of Dailies Total1. The outlook for Alcon for the rest of 2018 is continued growth in the low to mid single digits.

Commenting on the results, Vas Narasimhan, CEO of Novartis, said: “We continued our transformation this quarter to become a more focused medicines company. We expect the proposed sale of the OTC JV stake, the acquisition of AAA and the proposed acquisition of AveXis to provide significant sales, return on capital, and innovative R&D platforms that will strengthen our pipeline. Operationally, we drove solid growth across all financial metrics, strong performance across our key growth brands, and continued Alcon’s strong recovery.”

Click HERE for the full press release.

April 19, 2018May 20, 2026

Amédée: The Retro Style

In 1880, Jules Morel designed his very first collection of glasses in the heart of the Jura. They were exceptional frames, and the inspiration for the Marius Morel 1880 collection. Discover the elegance of these early designs with our Amédée concept.

The Amédée temple, nose and groove are crafted entirely of stainless steel. The titanium front is joined to the front end of the groove. The contrast between the two metals, their finishes and colours is subtly reminiscent of the combination frames of the 1950s. But with this new style, there are no imposing bridges. The layering of the metals results in a very fine, light frame.

The Amédée’s thin frame conceals numerous carefully-crafted details that impart a sophisticated style. The beaded groove creates elegant definition and catches the light. The finish on the front has a soft feel reminiscent of rubber and makes the frames even more comfortable.

These exceptional retro frames are available in four shapes: Little ovals, rounded shapes, pantos, and very thin rectangles.

The Amédée is available in metallic tones of gold, silver or black.

Distributed by Lanctôt: www.rlanctot.com